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Barrier to E. coli O157:H7 Growth in the Streptomycin-Treated
Mouse Intestine
Mary P. Leatham,1 Swati Banerjee,1 Steven M. Autieri,1 Regino Mercado-Lubo,1
Tyrrell Conway,2 and Paul S. Cohen1*
Department of Cell and Molecular Biology, University of Rhode Island, Kingston, Rhode Island 02881,1 and Department of
Botany and Microbiology, University of Oklahoma, Norman, Oklahoma 730192
Received 16 January 2009/Returned for modification 25 February 2009/Accepted 3 April 2009
Different Escherichia coli strains generally have the same metabolic capacity for growth on sugars in vitro,
but they appear to use different sugars in the streptomycin-treated mouse intestine (Fabich et al., Infect.
Immun. 76:1143–1152, 2008). Here, mice were precolonized with any of three human commensal strains (E. coli
MG1655, E. coli HS, or E. coli Nissle 1917) and 10 days later were fed 105 CFU of the same strains. While each
precolonized strain nearly eliminated its isogenic strain, confirming that colonization resistance can be
modeled in mice, each allowed growth of the other commensal strains to higher numbers, consistent with
different commensal E. coli strains using different nutrients in the intestine. Mice were also precolonized with
any of five commensal E. coli strains for 10 days and then were fed 105 CFU of E. coli EDL933, an O157:H7
pathogen. E. coli Nissle 1917 and E. coli EFC1 limited growth of E. coli EDL933 in the intestine (103 to 104
CFU/gram of feces), whereas E. coli MG1655, E. coli HS, and E. coli EFC2 allowed growth to higher numbers
(106 to 107 CFU/gram of feces). Importantly, when E. coli EDL933 was fed to mice previously co-colonized with
three E. coli strains (MG1655, HS, and Nissle 1917), it was eliminated from the intestine (<10 CFU/gram of
feces). These results confirm that commensal E. coli strains can provide a barrier to infection and suggest that
it may be possible to construct E. coli probiotic strains that prevent growth of pathogenic E. coli strains in the
intestine.
When a bacterial species indefinitely persists in stable num-
bers in the intestine of an animal, without repeated introduc-
tion of the bacterium to that animal, the animal’s intestine is
said to be colonized with that bacterium. The mammalian
intestine is colonized with thousands of species (50), collec-
tively known as the indigenous intestinal microbiota. Once
established, the intestinal microbiota is quite stable, and most
invading microorganisms fail to colonize. This phenomenon,
referred to as colonization resistance (60), can be explained in
part by a lag phase caused by both short-chain fatty acids and
hydrogen sulfide, which are metabolic end products of the
metabolism of the indigenous microbiota (22, 31). Thus, if the
numbers of an invading bacterium are small, they may be
completely eliminated from the intestine before exiting the lag
phase. However, even when the numbers of an invading bac-
terial species are large, the complete intestinal microbiota, in
most instances, still prevents its establishment, suggesting that
colonization resistance cannot be completely explained by an
extended lag phase (21, 23, 60).
An analogy can be drawn between the mammalian intestine
and a chemostat (23, 38). Two different microorganisms cannot
coexist in a chemostat when competing for a single limiting
nutrient; the one that utilizes that nutrient even slightly more
efficiently will eventually outcompete the other (18). However,
if two microorganisms utilize different growth-limiting nutri-
ents in a chemostat, they can coexist and maintain stable pop-
ulations (18, 58). Work with continuous-flow cultures in che-
mostats designed to mimic the intestine (21, 23) led to the
theory that being physically attached to the intestinal wall
allows a bacterial species to remain in the intestine despite
growing at a rate lower than the washout rate from the intes-
tine. Moreover, the theory predicts that two bacterial strains
competing for the same limiting nutrient can coexist in the
intestine if the metabolically less-efficient one is attached to the
intestinal wall (23). In addition, the data obtained from con-
tinuous-flow cultures show that if an established bacterium and
an invading one are equally fit to compete for the same limiting
nutrient, the invading bacterium will be eliminated by the es-
tablished bacterium if it is attached to the intestinal wall, be-
cause large wall populations can reduce the limiting nutrient
concentration to the point that an invader will not be able to
multiply in the lumen of the intestine at a rate fast enough to
resist washout (19, 22). Thus, according to the theory, the
mammalian intestine can be thought of as a chemostat in which
thousands of species of bacteria are in equilibrium, many being
physically attached to the host intestinal wall in large numbers,
and all competing for resources from a mixture of limiting
nutrients.
In support of the theory, when healthy human volunteers are
fed Escherichia coli strains isolated from their own feces, those
strains do not colonize (1). However, despite colonization re-
sistance, there appears to be a continuous succession of com-
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mensal E. coli strains in the mammalian intestine. In fact, an
average of five different E. coli strains can be found at any one
time in the feces of individual humans (2). Some strains are
present for months to years, while others persist only tran-
siently, i.e., for a few days. It therefore appears that, for com-
mensal E. coli strains, while colonization resistance is a pow-
erful mechanism, it is not completely effective. As such, it is
therefore possible that pathogenic E. coli strains take advan-
tage of incomplete colonization resistance among commensal
E. coli strains to initiate infection of the human intestine.
Why is colonization resistance incomplete for commensal E.
coli strains in the human intestine? One possibility is that there
are different epithelial cell receptors for different E. coli
strains, thereby allowing an invading commensal strain to resist
washout by first binding to the epithelium and then competing
with an established strain for the same limiting nutrient(s).
However, when the location of the human commensal strain E.
coli MG1655 was examined in the streptomycin-treated mouse
large intestine using in situ hybridization with species-specific
rRNA probes (51), it was found that E. coli MG1655 was not
associated with the intestinal epithelium (46) but was dispersed
as either single cells or dividing doublets in the mucus layer,
which overlays the epithelium and turns over about every 2 h
(52). The same was true of the rat commensal strain E. coli BJ4
(51). Therefore, if incomplete colonization resistance among
different commensal E. coli strains also occurs in the mouse
intestine, it is not likely due to adhesion of the strains to
different receptors on the intestinal epithelium.
Incomplete colonization resistance could be explained nu-
tritionally if different E. coli strains were to use different nu-
trients for growth in the intestine. Indeed, we recently reported
that the human commensal E. coli MG1655 and the human
enterohemorrhagic E. coli EDL933 do not use all the same
sugars for growth when each is the only E. coli strain in the
streptomycin-treated mouse intestine, despite being able to use
them all for growth in vitro (17). We found that E. coli EDL933
and E. coli MG1655 both use L-arabinose, L-fucose, D-maltose,
and N-acetyl-D-glucosamine in the mouse intestine, but E. coli
EDL933 uses three sugars not used by E. coli MG1655
(D-galactose, D-mannose, and D-ribose), whereas E. coli
MG1655 uses two sugars not used by E. coli EDL933 (sialic
acid and D-gluconate) (17). Moreover, different E. coli com-
mensals using different nutrients in the mouse intestine was
shown by the fact that, although the human commensal
strains E. coli MG1655 and E. coli Nissle 1917 both use L-
arabinose and L-fucose in the mouse intestine, E. coli Nissle
1917 also uses D-mannose, which is not used by E. coli MG1655
(13).
Clearly, the finding that different commensal E. coli strains
use different nutrients for growth in the mouse intestine is
consistent with incomplete colonization resistance among dif-
ferent commensal E. coli strains in the human intestine. How-
ever, whether the streptomycin-treated mouse intestine dis-
plays incomplete colonization resistance among different E.
coli strains has not been examined. In the present study, we
show that in this regard the mouse intestine mimics the human
intestine, i.e., when the streptomycin-treated mouse intestine is
precolonized with a commensal E. coli strain, it displays colo-
nization resistance against invasion by the same strain but
allows the growth of different commensal E. coli strains from
low to high numbers. Moreover, we show that although several
different human commensal E. coli strains individually display
incomplete colonization resistance against E. coli EDL933 (an
O157:H7 strain) to various degrees, simultaneous precoloniza-
tion of the streptomycin-treated mouse intestine with three
different commensal E. coli strains results in a completely ef-
fective barrier to subsequent E. coli EDL933 invasion.
MATERIALS AND METHODS
Bacterial strains. Bacterial strains used in this study are listed in Table 1. The
original E. coli strain K-12 was obtained from a stool sample from a convalescing
diphtheria patient in Palo Alto, CA, in 1922 (4). The sequenced E. coli MG1655
strain (CGSC 7740) was derived from the original K-12 strain, having only been
cured of the temperate bacteriophage lambda and the F plasmid by means of UV
light and acridine orange (4). It has an IS1 element in the flhDC promoter (6).
The E. coli MG1655 strain used in the present investigation is the sequenced
MG1655 strain, but lacking the IS1 element in the flhDC promoter (Table 1)
TABLE 1. Bacterial strains
E. coli strain Genotype/phenotype Referred to in text as: Source/reference
MG1655 (IS1) Strr No IS1 element in the flhDC promoter; resistant to
streptomycin
MG1655 and MG1655
Strr
26
MG1655 (IS1) Strr Nalr Spontaneous nalidixic acid-resistant mutant of MG1655
(IS1) Strr
MG1655 and MG1655
Strr Nalr
26
HS Human commensal strain Not applicable James Nataro
HS Strr Spontaneous streptomycin-resistant mutant of HS HS and HS Strr This study
HS Strr Nalr Spontaneous nalidixic acid-resistant mutant of HS Strr HS and HS Strr Nalr This study
Nissle 1917 Strr Spontaneous streptomycin-resistant mutant of Nissle
1917
Not applicable 3
Nissle 1917 Strr Nalr Spontaneous nalidixic acid-resistant mutant of Nissle
1917 Strr
Nissle 1917 and Nissle
1917 Strr Nalr
3
Nissle 1917 Strr lacZ::cat Mutant of Nissle 1917 Strr, unable to make -
galactosidase, resistant to streptomycin and
chloramphenicol
Nissle 1917 lacZ and
Nissle 1917 Strr
lacZ::cat
This study
EFC1 Human commensal strain Not applicable Michael Donnenberg
EFC1 Strr Spontaneous streptomycin-resistant mutant of EFC1 EFC1 and EFC1 Strr This study
EFC2 Human commensal strain Not applicable Michael Donnenberg
EFC2 Strr Spontaneous streptomycin-resistant mutant of EFC2 EFC2 and EFC2 Strr This study
F-18 Strr Nalr Spontaneous streptomycin and nalidixic acid-resistant
mutant of F-18
F-18 11
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(26). E. coli HS is a human commensal strain isolated from a laboratory scientist
at the Walter Reed Army Institute of Research (39). E. coli Nissle 1917 is a
human commensal strain that has been used as a probiotic agent since the early
1920s (55), and E. coli EDL933 is an O157:H7 strain isolated from an outbreak
caused by contaminated beef in 1982 (53). E. coli EFC1 and E. coli EFC2 were
each isolated from the feces of a healthy human (45).
Media and growth conditions. LB broth Lennox (Difco Laboratories, Detroit,
MI), LB agar Lennox (Difco), and MacConkey agar (Difco) were prepared
according to the package instructions. SOC medium was prepared as described
by Datsenko and Wanner (15). For colonization experiments, E. coli strains were
grown overnight in LB broth Lennox from an inoculum of about 106 CFU/ml to
about 109 CFU/ml. Cultures (10 ml) were incubated at 37°C with shaking in
125-ml tissue culture bottles. For testing the growth of strains in M9 minimal
medium (43) containing lactose as the sole carbon and energy source, overnight
cultures grown in LB broth Lennox were washed twice in M9 minimal medium
(no carbon source), 100 l of the washed cultures was transferred to 10 ml of M9
minimal medium containing lactose (0.4%, wt/wt) (Bacto-Lactose [Difco]), and
cultures were incubated at 37°C with shaking overnight in 125-ml tissue culture
bottles. Growth was monitored spectrophotometrically (A600) using a Pharmacia
Biotech Ultrospec 2000 UV/visible spectrophotometer.
Construction and characterization of E. coli Nissle 1917 Strr lacZ::cat. E. coli
Nissle 1917 Strr lacZ::cat was constructed by allelic exchange mutagenesis using
a chloramphenicol cassette, as described by Datsenko and Wanner (15). Primers
were designed by referring to the complete genome of E. coli MG1655 (6). The
primers used to construct the mutants were as follows: forward, 5-ACATG
TCTGACAATGGCAGATCCCAGCGGTCAAAACAGGCGGCAGTAAG
GTGTAGGCTGGAGCTGCTTCG-3; and reverse, 5-TTTTACAACGTCG
TGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCATATGAAT
ATCCTCCTTAGT-3. The construct was verified by PCR and sequencing.
As expected, the E. coli Nissle 1917 Strr lacZ::cat mutant failed to grow in M9
minimal medium containing lactose (0.4%, wt/wt) as the sole carbon source. The
2,700-bp deletion in the lacZ gene begins 76 bp downstream of the lacZ start
codon and ends 341 base pairs upstream of the TAA stop codon. The primers
used for confirming the size of the deletion by sequencing were as follows:
forward, 5-ATTGTAACAGTGGCCCGAAG-3; and reverse, 5-CGGATATC
TCGGTAGTGGGA-3. For sequencing, PCR products were purified with a
Qiagen Qiaquick PCR purification kit, following the manufacturer’s instructions.
PCR products were submitted to the Rhode Island Genomics and Sequencing
Center at the University of Rhode Island. After completion of the cycle sequenc-
ing, samples were purified with Agencourt’s CleanSEQ SPRI reagent and sep-
arated on an Applied Biosystems 3130xl genetic analyzer (50-cm capillary array
with POP7 polymer).
Mouse colonization experiments. Streptomycin-treated mice have been used
since 1954 to overcome the colonization resistance encountered in conventional
animals (8). In large part, colonization resistance is overcome in streptomycin-
treated mice by the loss of facultative anaerobes from the microbiota and by the
observed decrease in the concentrations of short-chain fatty acids and hydrogen
sulfide (32). The streptomycin-treated CD-1 mouse was used here to study the
competition in the intestine between streptomycin-resistant, wild-type E. coli
strains. Since the numbers of a strain of E. coli in mouse feces are a reflection of
their numbers in the mouse large intestine (14, 36), fecal counts were used to
judge the relative colonizing abilities of various E. coli strains. All the strains used
in this study are spontaneous streptomycin-resistant mutants, resistant to greater
than 2 mg/ml of streptomycin sulfate. E. coli MG1655 Strr, E. coli HS Strr, and
E. coli EDL933 Strr all contain the same point mutation in rpsL previously
reported for high-level streptomycin resistance in E. coli (24), in which amino
acid 44 has been changed from lysine (5-AAA-3) to threonine (5-ACA-3)
(M. P. Leatham, unpublished data), thereby eliminating the possibility that
differences observed in colonizing abilities among these strains could be due to
mutations in different genes that confer streptomycin resistance. E. coli Nissle
1917 Strr also has a point mutation in rpsL in amino acid 44, resulting in a change
from lysine (5-AAA-3) to arginine (5-AGA-3) (Leatham, unpublished). In
addition to being streptomycin resistant, some of the wild-type E. coli strains
used in the colonization experiments are resistant to either chloramphenicol,
nalidixic acid, or rifampin, genetic markers that have no effect on the coloniza-
tion abilities of the strains used in these studies (9, 44, 46).
Mice are given streptomycin sulfate in their drinking water (5 g/liter) over the
entire course of these experiments, which selectively removes facultative anaer-
obic E. coli, enterococci, streptococci, lactobacilli, and anaerobic lactobacilli and
bifidobacteria (32). Nevertheless, the overall populations of anaerobes, including
Bacteroides and Eubacterium, in the cecal contents following streptomycin treat-
ment are unchanged (32). Therefore, the streptomycin-treated mouse model
allows colonization by experimentally introduced E. coli strains and competition
with large numbers of strict anaerobes, and thus it is our model of choice for
studying competition among E. coli strains in the intestine (14, 36).
The specifics of the method used to compare the large intestine colonizing
abilities of E. coli strains in mice have been described previously (41, 56, 57, 62).
Briefly, three male CD-1 mice (5 to 8 weeks old) were given drinking water
containing streptomycin sulfate (5 g/liter) for 24 h to eliminate resident faculta-
tive bacteria (42). Following 18 h of starvation for food and water, the mice were
fed 1 ml of 20% (wt/vol) sucrose containing 105 CFU of LB broth Lennox-grown
E. coli strains, as described in Results. After ingesting the bacterial suspension,
both the food (Teklad mouse and rat diet; Harlan, Madison, WI) and strepto-
mycin-water were returned to the mice, and 1 g of feces was collected after 5 h,
24 h, and on odd-numbered days at the indicated times. Mice were housed
individually in cages without bedding and were placed in clean cages at 24-h
intervals. Fecal samples (one gram) were therefore no older than 24 h. Each fecal
sample was homogenized in 10 ml of 1% Bacto-Tryptone (Difco), diluted in the
same medium, and plated on MacConkey agar plates with appropriate antibiot-
ics. When appropriate, 1 ml of a fecal homogenate (sampled after the feces had
settled) was centrifuged at 12,000  g, resuspended in 100 l of 1% Bacto-
Tryptone, and plated on a MacConkey agar plate with appropriate antibiotics.
This procedure increases the sensitivity of the assay from 102 CFU/gram of feces
to 10 CFU/per gram of feces. To distinguish the various E. coli strains in feces,
dilutions were plated on lactose MacConkey agar containing streptomycin sul-
fate (100 g/ml); streptomycin sulfate (100 g/ml) and nalidixic acid (50 g/ml);
streptomycin sulfate (100 g/ml) and chloramphenicol (30 g/ml); or strepto-
mycin sulfate (100 g/ml) and rifampin (50 g/ml). Streptomycin sulfate, chlor-
amphenicol, and nalidixic acid were purchased from Sigma-Aldrich (St. Louis,
MO). Rifampin was purchased from Fisher Scientific (Pittsburgh, PA). All plates
were incubated for 18 to 24 h at 37°C prior to counting. When necessary, i.e., to
distinguish strains, 100 colonies from plates containing streptomycin were tooth-
picked onto MacConkey agar plates containing streptomycin and nalidixic acid
or onto MacConkey agar plates containing streptomycin and chloramphenicol.
Each colonization experiment was replicated at least twice, with essentially
identical results. Pooled data from at least two independent experiments (a total
of six mice) are presented in the figures.
Isolation and enumeration of E. coli strains from mouse intestinal mucus. E.
coli HS, E. coli MG1655, and E. coli Nissle 1917 lacZ were each fed to sets of
three mice. On day 22 postfeeding, the mice were sacrificed, and the ileum, the
rest of the small intestine, the cecum, and the colon were removed from each
mouse. Each section of the intestine was washed extensively with HEPES-Hanks
buffer (pH 7.2), and the mucus from each section of the intestine was scraped
into 5 ml of HEPES-Hanks buffer (pH 7.2), as described previously (10). Each
sample was homogenized by vortexing and then plated on MacConkey agar with
appropriate antibiotics. Plates were incubated for 18 to 24 h at 37°C prior to
counting. To distinguish strains, 100 colonies were toothpicked as described
above. The number of CFU per intestinal section for each strain was calculated
from the CFU per milliliter by multiplying by the total volume (in milliliters) of
each mucus sample.
Colicin and microcin assays. Colicin and microcin activity was assayed as
described by Patzer et al. (49). Briefly, bacteria to be tested for colicin or
microcin activity were streaked on nutrient broth dipyridyl plates (nutrient broth
[Difco], 8 g/liter; NaCl, 5 g/liter; Bacto agar [Difco], 15 g/liter; 2,2 dipyridyl
[Sigma-Aldrich Corp., St. Louis, MO], 0.2 mM) and incubated overnight at 37°C.
Indicator strains were grown overnight in LB broth Lennox at 37°C with shaking
in 125-ml tissue culture bottles. For colicin or microcin testing, 105 CFU or 106
CFU of an indicator strain was added to 3 ml of nutrient broth soft agar (nutrient
broth, 8 g/liter; NaCl, 5 g/liter; Bacto agar, 15 g/liter), which was then poured
onto a 20-ml nutrient broth dipyridyl plate. After the nutrient broth soft agar
solidified, strains to be tested for colicin or microcin activity on the indicator
strain were toothpicked onto the plate. Plates were incubated overnight at 37°C,
and zones of growth inhibition were measured.
RESULTS
Mice precolonized with a human commensal E. coli strain
are resistant to subsequent intestinal colonization by the same
strain. When healthy human volunteers are fed E. coli strains
isolated from their own feces, those strains do not colonize (1).
This is an example of colonization resistance (2). If coloniza-
tion resistance occurs in the streptomycin-treated mouse for
individual E. coli strains, it would be expected that if mice were
precolonized with a human commensal E. coli strain for 10
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days and were then fed low numbers of the same strain, the
strain fed at day 10 would have a difficult time colonizing the
mouse intestine. To test this hypothesis, mice were precolo-
nized for 10 days with any of three human commensal strains:
E. coli MG1655 Strr, E. coli Nissle 1917 Strr Nalr, or E. coli HS
Strr. On day 10, the mice precolonized with E. coli MG1655
Strr were fed 105 CFU of E. coli MG1655 Strr Nalr, the mice
precolonized with E. coli Nissle 1917 Strr Nalr were fed 105
CFU of E. coli Nissle 1917 Strr Rifr, and the mice precolonized
with E. coli HS Strr were fed 105 CFU of E. coli HS Strr Nalr.
Precolonized E. coli MG1655 nearly eliminated the E. coli
MG1655 that was fed to the mice on day 10 (Fig. 1A), pre-
colonized E. coli HS nearly eliminated the E. coli HS that was
fed to the mice on day 10 (Fig. 1B), and precolonized E. coli
Nissle 1917 nearly eliminated the E. coli Nissle 1917 that was
fed to the mice on day 10 (Fig. 1C). Thus, the streptomycin-
treated mouse model of intestinal colonization also exhibits
colonization resistance, as observed in humans (1). When a
mouse is fed an E. coli strain that is already residing in its
intestine, the new strain has great difficulty in colonizing.
Mice precolonized with a human commensal E. coli strain
cannot prevent subsequent intestinal colonization by a differ-
ent human commensal E. coli strain. It was not surprising that
mice precolonized with a human commensal E. coli strain were
resistant to colonization by the same strain fed to the mice 10
days later, since both the precolonized strain and the strain fed
at day 10 are isogenic and presumably utilize all nutrients
equally well, and the precolonized strain had the advantage of
10 days to adapt physiologically and genetically (26, 27, 37) to
the intestinal environment. However, evidence is mounting
that different human E. coli strains are different with respect to
nutrient utilization in the mouse intestine (13, 17). In view of
this evidence, it seemed possible that mice precolonized with
one human commensal E. coli strain might allow subsequent
intestinal colonization by a different human commensal E. coli
strain. To this end, mice precolonized with E. coli MG1655 Strr
were fed 105 CFU of E. coli HS Strr Nalr, mice precolonized
with E. coli MG1655 Strr Nalr were fed 105 CFU of E. coli
Nissle 1917 Strr Rifr, mice precolonized with E. coli HS Strr
were fed 105 CFU of either E. coli MG1655 Strr Nalr or E. coli
Nissle 1917 Strr Rifr, and mice precolonized with E. coli Nissle
1917 Strr Rifr were fed 105 CFU of either E. coli MG1655 Strr
Nalr or E. coli HS Strr Nalr. Indeed, E. coli HS and E. coli
Nissle 1917 were able to grow in the intestine from low num-
bers to about the level of precolonized E. coli MG1655 (Fig.
2A and B), E. coli MG1655 and E. coli Nissle 1917 were able
to grow from low numbers to about the level of E. coli HS in
the intestines of mice precolonized with E. coli HS (Fig. 2C and
D), and E. coli MG1655 and E. coli HS were able to grow from
low to relatively high numbers in the intestines of mice pre-
colonized with E. coli Nissle 1917, although they did not reach
the level of E. coli Nissle 1917 (Fig. 2E and F). Since each of
the precolonized commensal E. coli strains nearly eliminated
its isogenic strain from the mouse intestine (Fig. 1), and since
different E. coli strains use different nutrients for growth in the
mouse intestine (13, 17), these data suggest that each different
commensal E. coli strain either uses one or more nutrients not
used by the other two commensal E. coli strains to grow in the
mouse intestine or uses one or more nutrients better than each
of the other two strains.
FIG. 1. A precolonized E. coli strain prevents the same strain from
colonizing the mouse intestine. Sets of three mice were fed 105 CFU of
a human commensal strain and 10 days later were fed 105 CFU of the
same strain. (A) E. coli MG1655 Strr (f) and, 10 days later, E. coli
MG1655 Strr Nalr (Œ). (B) E. coli HS Strr (f) and, 10 days later, E. coli
HS Strr Nalr (Œ). (C) E. coli Nissle 1917 Strr Nalr (f) and, 10 days
later, 105 CFU of E. coli Nissle 1917 Strr Rifr (Œ). At the indicated
times, fecal samples were homogenized, diluted, and plated as de-
scribed in Materials and Methods. Data from two independent exper-
iments (six mice) are shown. Bars represent the standard errors of the
log10 means of CFU per gram of feces for six mice.
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FIG. 2. E. coli human commensal strains can colonize the intestines of mice precolonized with different human E. coli commensal strains.
(A) Sets of three mice were fed 105 CFU of E. coli MG1655 Strr (f) and, 10 days later, were fed 105 CFU of E. coli HS Strr Nalr (Œ). (B) Sets
of three mice were fed 105 CFU of E. coli MG1655 Strr Nalr (f) and, 10 days later, were fed 105 CFU of E. coli Nissle 1917 Strr Rifr (Œ). (C) Sets
of three mice were fed 105 CFU of E. coli HS Strr (f) and, 10 days later, were fed 105 CFU of E. coli MG1655 Strr Nalr (Œ). (D) Sets of three
mice were fed 105 CFU of E. coli HS Strr Nalr (f) and, 10 days later, were fed 105 CFU of E. coli Nissle 1917 Strr Rifr (Œ). (E) Sets of three mice
were fed 105 CFU of E. coli Nissle 1917 Strr Rifr (f) and, 10 days later, were fed 105 CFU of E. coli MG1655 Strr Nalr (Œ). (F) Sets of three mice
were fed 105 CFU of E. coli Nissle 1917 Strr Rifr (f) and, 10 days later, were fed 105 CFU of E. coli HS Strr Nalr (Œ). Data were collected and
plotted as described in the legend to Fig. 1.
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Growth of wild-type E. coli EDL933 in mice precolonized
with either E. coli MG1655, E. coli HS, E. coli Nissle 1917, E.
coli EFC1, or E. coli EFC2. Since commensal E. coli strains are
normal members of the human intestinal microbiota, and a
healthy human carries an average of five different E. coli
strains in the intestine (2), it seems reasonable to assume that
any human that becomes infected with an enterohemorrhagic
E. coli (EHEC) strain was colonized with at least one com-
mensal E. coli strain prior to becoming infected. EHEC strains,
such as E. coli EDL933, grow from very low numbers to ex-
tremely high numbers in the intestines of humans that develop
disease (34). In fact, many people shed high numbers of EHEC
(106 to 108 CFU/gram of feces) for several weeks after the
onset of diarrhea (35). Therefore, it appears that invading
EHEC strains can grow in the presence of commensal strains
that inhabit the intestine. However, many humans that eat
EHEC-contaminated foods do not develop disease symptoms
(47). It therefore seemed possible, in view of the fact that
different E. coli strains use different sugars for growth in the
intestine (13, 17), that some precolonized commensal E. coli
strains do not allow EHEC strains to grow to high numbers in
the intestine. To address this possibility, mice were fed any of
five human commensal strains (E. coli MG1655 Strr Nalr, E.
coli HS Strr Nalr, E. coli Nissle 1917 Strr Nalr, E. coli EFC1
Strr, or E. coli EFC2 Strr) and 10 days later were fed 105 CFU
of the EHEC strain E. coli EDL933 Strr Rifr. Indeed, three
different results were obtained. In mice precolonized with E.
coli HS, E. coli EDL933 grew from 105 CFU/gram of feces to
about 5  107 CFU/gram of feces (Fig. 3A). This level of
growth of an E. coli O157:H7 strain has been observed previ-
ously in mice precolonized with a commensal E. coli strain
(25). In mice precolonized with either E. coli MG1655 or E.
coli EFC2, E. coli EDL933 grew from 105 CFU/gram of feces
to about 106 CFU/gram of feces (Fig. 3B and C). However, in
mice precolonized with either E. coli EFC1 or E. coli Nissle
1917, E. coli EDL933 dropped from 105 CFU/gram of feces to
between 103 and 104 CFU/gram of feces (Fig. 3D and E).
Therefore, different resident commensal E. coli strains vary by
as much as 10,000-fold with respect to the level of carriage of
the E. coli EDL933 that they allow in the mouse intestine.
Growth of wild-type E. coli EDL933 in mice precolonized
with E. coli MG1655, E. coli HS, and E. coli Nissle 1917. If
different commensal E. coli strains use different nutrients for
growth in the intestine, it would be expected that nutrients
would be more limited for E. coli EDL933 growth in mice
precolonized with three different commensal E. coli strains
than in mice precolonized with only one commensal E. coli
strain. To address this possibility, mice were precolonized with
E. coli MG1655 Strr Nalr, E. coli HS Strr, and E. coli Nissle
1917 Strr lacZ::cat. In control experiments, E. coli Nissle 1917
lacZ had the same colonizing ability as wild-type E. coli Nissle
1917 (data not shown) and was used because it is chloram-
phenicol resistant (Table 1) and can be selected on plates
containing chloramphenicol. Ten days after precolonizing with
the three commensal E. coli strains, the mice were fed 105 CFU
of E. coli EDL933 Strr Rifr (Fig. 3F). In these experiments, the
limit of detection of E. coli EDL933 was 10 CFU/gram of feces
(see Materials and Methods). After E. coli EDL933 was fed to
the mice, E. coli Nissle 1917 lacZ colonized at a level of about
108 CFU/gram of feces, E. coli HS at a level of about 107
CFU/gram of feces, and E. coli MG1655 at a level between 105
and 106 CFU/gram of feces (Fig. 3F). In contrast, E. coli
EDL933 dropped from about 105 CFU/gram of feces at 1 day
postfeeding to 10 CFU/gram of feces 10 days later, a 10,000-
fold decrease to an undetectable level. This difference repre-
sents a 50-fold reduction in E. coli EDL933 in mice precolo-
nized with E. coli MG1655, E. coli HS, and E. coli Nissle 1917
compared to the level in mice precolonized with E. coli Nissle
1917 alone (compare Fig. 3E and F). Clearly, the three com-
mensal strains were far more effective in protecting against E.
coli EDL933 growth in the mouse intestine than any of the
commensal strains alone.
Colicin and microcin production. E. coli Nissle 1917 is
known to produce microcins M and H47 (49), and many E. coli
strains produce colicins. Therefore, the ability of the different
commensal E. coli strains to limit E. coli EDL933 colonization
to various degrees could be due in part to colicin or microcin
production. However, when E. coli Nissle 1917, E. coli
MG1655, and E. coli HS were tested for the ability to inhibit E.
coli EDL933 growth on nutrient broth dipyridyl plates (see
Materials and Methods), none were able to do so. If E. coli
Nissle 1917 microcins were active against E. coli EDL933,
growth inhibition would have been seen, since E. coli Nissle
1917 inhibited the growth of E. coli MG1655 (	1.5-mm zone
of inhibition). E. coli Nissle 1917 did not inhibit the growth of
E. coli HS. Furthermore, E. coli MG1655 did not inhibit the
growth of E. coli HS or E. coli Nissle 1917, and E. coli HS did
not inhibit the growth of E. coli MG1655 or E. coli Nissle 1917.
In further support of the validity of the assay, E. coli F-18,
which produces ColV (30), inhibited the growth of E. coli
MG1655 (	4.0-mm zone of inhibition), E. coli HS (	9.0-mm
zone of inhibition), and to a very limited extent, the growth of
E. coli EDL933 (	1.0-mm zone of inhibition). These results
suggest that none of the commensal strains used in the colo-
nization experiments produce an antimicrobial that limits the
growth of E. coli EDL933.
Location of E. coli HS, E. coli MG1655, and E. coli Nissle
1917 lacZ along the length of the mouse gastrointestinal
tract. The ability of several E. coli strains, including E. coli
EDL933, to grow in mouse intestinal mucus has been corre-
lated with their ability to colonize the mouse large intestine,
i.e., they grow rapidly in cecal mucus in vitro but far more
slowly or not at all in cecal luminal contents (40, 48, 56, 57, 61).
However, it was still possible that the ability of either E. coli
HS, E. coli MG1655, or E. coli Nissle 1917 to grow from low to
higher numbers in the intestines of mice precolonized with a
different E. coli strain was due to the preference of each strain
for a different location in the intestine, e.g., one strain might
grow preferentially in the cecum and another in the ileum. To
test this hypothesis, 22 days after feeding the mice 105 CFU of
E. coli HS, E. coli MG1655, and E. coli Nissle 1917 lacZ, the
numbers of each strain in the ileal mucus, the mucus isolated
from the rest of the small intestine, the cecal mucus, and the
colonic mucus were determined. This experiment was con-
ducted at the conclusion of the experiment shown in Fig. 3F.
As shown in Table 2, although the numbers of each strain were
highest in cecal and colonic mucus, there were considerable
numbers of each strain in small intestine mucus and in ileal
mucus. Moreover, the relative numbers of the strains in each
mucus preparation reflected the relative numbers of the strains
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FIG. 3. E. coli EDL933 colonization of the mouse intestine precolonized with different commensal strains. (A) Sets of three mice were fed 105
CFU of E. coli HS Strr Nalr (f) and, 10 days later, were fed 105 CFU of E. coli EDL933 Strr Rifr (Œ). (B) Sets of three mice were fed 105 CFU
of E. coli MG1655 Strr Nalr (f) and, 10 days later, were fed 105 CFU of E. coli EDL933 Strr Rifr (Œ). (C) Sets of three mice were fed 105 CFU
of E. coli EFC2 Strr (f) and, 10 days later, were fed 105 CFU of E. coli EDL933 Strr Rifr (Œ). (D) Sets of three mice were fed 105 CFU of E. coli
EFC1 Strr (f) and, 10 days later, were fed 105 CFU of E. coli EDL933 Strr Rifr (Œ). (E) Sets of three mice were fed 105 CFU of E. coli Nissle
Strr Nalr (f) and, 10 days later, were fed 105 CFU of E. coli EDL933 Strr Rifr (Œ). (F) Sets of three mice were fed 105 CFU of E. coli HS Strr
(f), E. coli MG1655 Strr Nalr (F), and E. coli Nissle 1917 Strr lacZ::cat (‚) and, 10 days later, were fed 105 CFU of E. coli EDL933 Strr Rifr
(Œ). Data were collected and plotted as described in the legend to Fig. 1.
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in the other mucus preparations and in feces (Table 2). It
therefore appears that neither E. coli HS, E. coli MG1655, nor
E. coli Nissle 1917 lacZ has a preference for a specific site
when competing with the others in the mouse intestine. It
should also be mentioned that although E. coli EDL933 was
not detectable in the mucus preparations in these experiments,
it is also found in the mucus in each of the intestinal sections
when it is the only E. coli strain fed to mice (44).
DISCUSSION
In the present study, we demonstrate colonization resistance
in mice precolonized with a specific human commensal E. coli
strain and subsequently fed the same strain 10 days later, i.e.,
the strain fed at day 10 is nearly eliminated (Fig. 1). However,
despite the fact that different human commensal strains com-
pete with each other in all sections of the intestine (Table 2),
it appears that colonization resistance is not effective when
mice precolonized with one human commensal E. coli strain
are fed 105 CFU of a different human commensal E. coli strain
10 days later. That is, the strain fed at day 10 grows from low
to higher numbers in the mouse intestine and persists in high
numbers along with the precolonized strain (Fig. 2).
When the precolonized E. coli strain and the strain fed at 10
days are isogenic and utilize all nutrients equally well, the
precolonized strain has the advantage of having had 10 days to
adapt to the intestinal environment. The mechanisms involved
in adaptation that result in colonization resistance are largely
unknown. Freter argued that adhesion to the intestinal epithe-
lium would impart a major advantage to the precolonized
strain, resulting in the elimination of the invading strain (19,
20, 21). However, this explanation is unlikely in the present
case, since the human commensal strain E. coli MG1655 does
not associate with the intestinal epithelium (46) but still dis-
plays colonization resistance against itself (Fig. 1A). It has
been shown that precolonized commensal E. coli strains can
adapt genetically to the mouse intestine such that they become
better colonizers of the mouse intestine than their parents by
using nutrients more efficiently (26, 27, 37). Whatever the
mechanism of adaptation of a precolonized strain to the mouse
intestine, whether it be genetic, physiological, or both, it is
clear that colonization resistance is effective when mice pre-
colonized with a commensal E. coli strain are fed the same E.
coli strain (Fig. 1) but ineffective when precolonized mice are
fed a different E. coli strain (Fig. 2). Furthermore, since it
appears that different E. coli strains have different nutritional
programs for growth in the intestine (13, 17), it seems likely
that nonisogenic strains fail to display colonization resistance
for nutritional reasons. That is, when the precolonized E. coli
strain and the E. coli strain fed at day 10 are strains isolated
from different humans, and the strain fed at day 10 grows from
low to higher numbers, without eliminating the precolonized
strain, we hypothesize that it does so either by using one or
more nutrients not being used by the precolonized strain or by
outcompeting it for one or more nutrients; however, we fully
recognize that E. coli colonization may be impacted by several
other factors, including interaction with the indigenous micro-
biota (21, 50), innate immunity (12), and competition for iron
(59).
As stated above, the results presented here are consistent
with our previous finding that different E. coli strains have
different nutritional programs in the mouse intestine (13, 14).
In this vein, it will be of great interest to determine whether a
specific commensal E. coli strain uses the same nutrients for
growth when it is the only E. coli strain in the mouse intestine
as it does when it grows from low to high numbers in mice
precolonized with a different commensal E. coli strain. Of
equal interest will be to determine whether a specific commen-
sal E. coli strain uses the same or different nutrients for growth
in the intestines of mice precolonized with different commen-
sal E. coli strains, e.g., does E. coli Nissle 1917 use the same
nutrients to grow from low to high numbers in mice precolo-
nized with E. coli MG1655 as it does in mice precolonized with
E. coli HS?
Precolonized E. coli Nissle 1917 allowed growth of both E.
coli MG1655 and E. coli HS to between 106 and 107 CFU/gram
of feces (Fig. 2E and F) but limited E. coli EDL933 to levels
between 103 and 104 CFU/gram of feces (Fig. 3E). Therefore,
it appears that in the mouse intestine E. coli Nissle 1917 allows
commensal E. coli strains to grow to levels up to 1,000-fold
greater than the levels of EHEC strain E. coli EDL933 that it
allows. E. coli Nissle 1917 is a commensal strain that has been
used as a probiotic agent to treat gastrointestinal infections in
humans since the early 1920s (54). Several features of E. coli
Nissle 1917 have been proposed to be responsible for its pro-
biotic nature, including its ability to express two microcins (35),
the absence of known protein toxins, its semirough lipopoly-
saccharide, and hence its serum sensitivity (7, 30), and the
presence of six iron uptake systems (29). At the present time,
we cannot rule out the possibility that E. coli Nissle 1917
inhibits the growth of E. coli EDL933 in the mouse intestine
via a secreted inhibitory substance; however, as reported here,
E. coli Nissle 1917 produces no inhibitory substance against E.
coli EDL933 in microcin assays. Thus, we favor the hypothesis
that the nutrients available to E. coli EDL933 and their con-
centrations in the intestine are far less in mice precolonized
with E. coli Nissle 1917 than are available to either E. coli
MG1655 or E. coli HS, e.g., for reasons presently unknown, it
may be that E. coli Nissle 1917 is able to outcompete E. coli
EDL933, but not E. coli MG1655 or E. coli HS, for one or
more major nutrients in the intestine.
It is interesting to note that E. coli EDL933 was able to grow
TABLE 2. E. coli HS, E. coli MG1655, and E. coli Nissle 1917
lacZ::cat in small intestine mucus, ileal mucus, cecal mucus,
colonic mucus, and feces
Location
Log10 CFUa
E. coli HS E. coliMG1655
E. coli Nissle
1917
lacZ
Small intestine mucusb 4.4 
 0.3 2.3 
 0.5 4.7 
 0.3
Ileal mucus 3.2 
 0.6 1.9 
 0.4 4.1 
 0.4
Cecal mucus 4.8 
 0.4 3.8 
 0.6 6.4 
 0.2
Colonic mucus 4.6 
 0.4 3.4 
 0.6 5.9 
 0.4
Feces 6.9 
 0.3 5.7 
 0.5 8.2 
 0.1
a The values are log10 means 
 standard errors of the means for six mice.
Mucus preparations were isolated on day 22 after feeding. The CFU value for
each mucus preparation is corrected for the entire volume of the preparation.
The fecal values are the CFU/gram of feces at 21 days after feeding.
b Mucus from immediately below the stomach to the proximal ileum.
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from 105 CFU/gram of feces to 5  107 CFU per gram of feces
in mice precolonized with E. coli HS (Fig. 3A) but the level
dropped to 5  103 CFU/gram of feces in mice precolonized
with E. coli Nissle 1917 (Fig. 3E). How can these data be
explained on a nutritional basis? It should be noted that E. coli
Nissle 1917 was able to grow to the level of E. coli HS in mice
precolonized with E. coli HS (Fig. 2D); although E. coli HS was
able to grow from 105 CFU/gram of feces to 106 CFU/gram of
feces in mice precolonized with E. coli Nissle 1917, that level
was still 100-fold lower than that of E. coli Nissle 1917 (Fig.
2F). Thus, it would appear that although E. coli HS can either
use a nutrient(s) that E. coli Nissle 1917 does not use or uses
it better, overall E. coli 1917 is the nutritionally superior strain
in the intestine, most likely filling more nutritional niches than
E. coli HS. If so, it is not surprising that E. coli EDL933 was
able to grow much better in mice precolonized with E. coli HS
than in mice precolonized with E. coli Nissle 1917.
The fact that E. coli EDL933 growth in the intestine is
severely limited, such that it persists in the intestine at a level
of almost 5 orders of magnitude lower than E. coli Nissle 1917
in mice precolonized with E. coli Nissle 1917, says nothing as to
whether the same scenario in the human intestine would or
would not lead to disease. It must be remembered that colo-
nization is only the first step in infection and that the mouse
intestine is strictly a model for E. coli EDL933 colonization,
not pathogenesis. Hemorrhagic colitis in humans is character-
ized by hemorrhage and edema in the lamina propria and
bloody diarrhea (28, 34). It is possible that although an EHEC
strain in the human might also be initially limited to a low level
of growth in the intestine due to limiting nutrient levels caused
by the resident E. coli strain, as long as the relatively few
EHEC cells are healthy and able to persist at that low level,
they might be able to initiate the pathogenic process by dam-
aging the mucosa. If so, blood would enter the intestine and
expose the EHEC cells to a new rich source of nutrients,
leading to increased EHEC growth and subsequent disease. If
this scenario is true, one approach to preventing disease would
be to precolonize humans with one or more E. coli strains that
would not allow any growth of ingested EHEC cells, i.e., that
would occupy all E. coli nutritional niches, thereby leading to
complete EHEC elimination from the intestine prior to the
onset of disease. That this approach to preventing EHEC col-
onization may have merit is shown by the fact that E. coli
EDL933 fed at day 10 was eliminated (10 CFU/gram of
feces) from the intestines of mice precolonized with E. coli
Nissle 1917, E. coli HS, and E. coli MG1655, rather than
colonizing at a level of about 5  103 CFU/gram of feces for
several days as in mice precolonized with just E. coli Nissle
1917 (compare Fig. 3E and F).
The usual commentary in E. coli comparative genomics pa-
pers is that the genomic core genomes and hence the metabo-
lomes of various E. coli strains are nearly identical (33, 55). If
so, why is it that commensal E. coli strains fed to mice at day
10 can grow from low to high numbers in mice precolonized
with different commensal E. coli strains, i.e., why do they use
different nutrients? With rare exceptions, it is certainly not
because those strains that do not use a particular nutrient in
the intestine do not have the ability to use it, e.g., E. coli
MG1655 uses sialic acid for growth in the intestine whereas E.
coli EDL933 does not, but both strains can use sialic acid for
growth in vitro (17). We think it is possible that the observed
colonization differences in competition between different E.
coli commensals, as well as between commensal E. coli strains
and E. coli EDL933, may be manifestations of the differing
efficiencies with which each strain can occupy specific nutri-
tional niches. That is, both strains might compete for a specific
nutrient, but not equally well, e.g., one strain might have more
kinetically efficient pathways for uptake and catabolism of that
nutrient or each strain might have the same pathways for
uptake and catabolism of the nutrient, but those pathways
might be more highly induced in one strain than in the other.
Alternatively, it may be that non-core genes (5, 16) play a
major role in choosing the nutrients that are used by different
E. coli strains in the intestine. Further research designed to
understand the mechanisms by which different E. coli strains
choose specific nutrients for growth in the intestine should
provide a nutritional framework for the rational design of E.
coli commensal strains (i.e., probiotics) that can serve as the
first line of defense in protecting humans against colonization
by E. coli intestinal pathogens.
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